Am J Perinatol
DOI: 10.1055/a-1906-9048
Original Article

The Clinical Significance of Extreme Leukocytosis among Newborns: A Retrospective Cohort Study

Oryan Golomb*
1   Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
,
Irit Schushan-Eisen*
1   Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
2   Department of Neonatology, The Edmond and Lili Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel
,
Ayala Maayan-Metzger
1   Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
2   Department of Neonatology, The Edmond and Lili Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel
,
1   Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
2   Department of Neonatology, The Edmond and Lili Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel
,
Tzipora Strauss
1   Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
2   Department of Neonatology, The Edmond and Lili Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel
,
Ram Mazkereth
1   Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
2   Department of Neonatology, The Edmond and Lili Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel
› Author Affiliations

Abstract

Objective The aim of the study is to examine the clinical significance of extreme leukocytosis (>40,000 cells/µL) at birth among neonates.

Study Design Data were retrospectively collected on 208 infants with leukocytosis >40,000 cells/µL and on matched normal controls as determined in complete blood counts obtained on the first day of life.

Results There were no significant group differences in birth weight, Apgar's score, timing of respiratory support, hospitalization in special care units or rehospitalization during the first month of life. All neonates with leukocytosis received antibiotics. The blood cultures of both groups were negative. A multivariate analysis showed that leukocytosis did not predict either the presence of symptoms associated with sepsis among neonates or hospitalization in a neonatal special care unit.

Conclusion Extreme leukocytosis on the first day of life is a poor predictor of infection. Clinicians should decide upon treatment according to risk factors and symptoms but not according to the degree of leukocytosis.

Key Points

  • Extreme leukocytosis on the first day of life is a poor predictor of infection.

  • Clinicians should decide upon treatment according to risk factors and symptoms.

  • Leukocytosis was not predictive of a higher risk of morbidity in neonates.

Note

This work was performed in partial fulfillment of the MD thesis requirements of the Sackler Faculty of Medicine, Tel Aviv University (OG).


* These authors contributed equally to this work.




Publication History

Received: 13 January 2022

Accepted: 11 July 2022

Accepted Manuscript online:
21 July 2022

Article published online:
29 December 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Murphy K, Weiner J. Use of leukocyte counts in evaluation of early-onset neonatal sepsis. Pediatr Infect Dis J 2012; 31 (01) 16-19
  • 2 Haslam DB. Epidemiology of infections. In: Kliegman RM, ST Geme JW, Blum, NJ, Shah SS, Wilson KM, eds. Nelson Textbook of Pediatrics. 21st ed. Philadelphia, PA: Elsevier; 2020: 996-1005
  • 3 Simonsen KA, Anderson-Berry AL, Delair SF, Davies HD. Early-onset neonatal sepsis. Clin Microbiol Rev 2014; 27 (01) 21-47
  • 4 Lim WH, Lien R, Huang YC. et al. Prevalence and pathogen distribution of neonatal sepsis among very-low-birth-weight infants. Pediatr Neonatol 2012; 53 (04) 228-234
  • 5 Churgay CA, Smith MA, Blok B. Maternal fever during labor–what does it mean?. J Am Board Fam Pract 1994; 7 (01) 14-24
  • 6 Newman TB, Maisels MJ. Evaluation and treatment of jaundice in the term newborn: a kinder, gentler approach. Pediatrics 1992; 89 (5 Pt 1): 809-818
  • 7 Ottolini MC, Lundgren K, Mirkinson LJ, Cason S, Ottolini MG. Utility of complete blood count and blood culture screening to diagnose neonatal sepsis in the asymptomatic at risk newborn. Pediatr Infect Dis J 2003; 22 (05) 430-434
  • 8 Polin RA. Committee on Fetus and Newborn. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics 2012; 129 (05) 1006-1015
  • 9 Newman TB, Puopolo KM, Wi S, Draper D, Escobar GJ. Interpreting complete blood counts soon after birth in newborns at risk for sepsis. Pediatrics 2010; 126 (05) 903-909
  • 10 Hermansen MC. Nucleated red blood cells in the fetus and newborn. Arch Dis Child Fetal Neonatal Ed 2001; 84 (03) F211-F215
  • 11 Manroe BL, Weinberg AG, Rosenfeld CR, Browne R. The neonatal blood count in health and disease. I. Reference values for neutrophilic cells. J Pediatr 1979; 95 (01) 89-98
  • 12 Morag I, Dunn M, Nayot D, Shah PS. Leukocytosis in very low birth weight neonates: associated clinical factors and neonatal outcomes. J Perinatol 2008; 28 (10) 680-684
  • 13 Barone MA. The Harriet Lane Handbook. 14th ed. St. Louis, MO: Mosby; 1996: 294
  • 14 Bennet R, Eriksson M, Nord CE, Zetterström R. Suppression of aerobic and anaerobic faecal flora in newborns receiving parenteral gentamicin and ampicillin. Acta Paediatr Scand 1982; 71 (04) 559-562
  • 15 Bitner-Glindzicz M, Rahman S. Ototoxicity caused by aminoglycosides. BMJ 2007; 335 (7624): 784-785
  • 16 Hornik CP, Benjamin DK, Becker KC. et al. Use of the complete blood cell count in late-onset neonatal sepsis. Pediatr Infect Dis J 2012; 31 (08) 803-807
  • 17 Kaplan M, Wong RJ, Sibley E, Stevenson DK. Neonatal jaundice and liver disease. In: Martin RJ, Fanaroff AA, Walsh MC, eds. Neonatal-Perinatal Medicine: Diseases of the Fetus and Infant. 9th ed. St. Louis, MO: Elsevier Mosby; 2011: 1443